caregen.official

Welcome to Caregen! 💚

🤝 A Warm Welcome to Our Partners from Brazil

Caregen Co., Ltd. was pleased to welcome representatives from BCMED and Soldiers Nutrition to our headquarters.

The visiting team included Alvaro de Freitas Almeida (CEO) and Danielly Dantas Almeida from BCMED, along with Yuri Silveira de Abreu (CEO), Vitor Norio Tanoue Suzuki, Fabiula de Arruda Freire, and Eder Ferreira Marques from Soldiers Nutrition.

During the visit, the guests toured Caregen’s research laboratories and explored Caregen’s biomimetic peptide technologies and R&D capabilities.

It was a valuable opportunity to exchange insights, discuss future collaboration, and further strengthen the partnership between our companies.

Caregen sincerely appreciates their visit and looks forward to continued collaboration ahead.

From Seoul to the world !
Brazilian partners experience the science of Dermaheal Luxidase™ firsthand at Caregen’s R&D center in Korea.
Real people. Real results. Right here.
Our international buyers don‘t just take our word for it — they feel the difference themselves. ✨

Welcome to Caregen! 💚

🤝 A Warm Welcome to Our Partners from Brazil

Caregen Co., Ltd. was pleased to welcome representatives from BCMED and Soldiers Nutrition to our headquarters.

The visiting team included Alvaro de Freitas Almeida (CEO) and Danielly Dantas Almeida from BCMED, along with Yuri Silveira de Abreu (CEO), Vitor Norio Tanoue Suzuki, Fabiula de Arruda Freire, and Eder Ferreira Marques from Soldiers Nutrition.

During the visit, the guests toured Caregen’s research laboratories and explored Caregen’s biomimetic peptide technologies and R&D capabilities.

It was a valuable opportunity to exchange insights, discuss future collaboration, and further strengthen the partnership between our companies.

Caregen sincerely appreciates their visit and looks forward to continued collaboration ahead.

Caregen Expands U.S. Retail Presence Through Partnership with 2San 🇺🇸

Caregen has partnered with U.S. healthcare distribution company 2San to expand its peptide-based wellness products across the U.S. consumer retail market.

Beginning with Korglutide, the collaboration is expected to gradually broaden to include MyoKi and ProGsterol through major retail and pharmacy channels. The products are part of Caregen’s growing metabolic wellness portfolio, focusing on weight management, muscle health, and blood sugar wellness.

🔹 Korglutide: Next-generation GLP-1R/IGF-1R metabolic peptide
🔹 MyoKi: Advanced muscle enhancement & recovery
🔹 ProGsterol: Peptide innovation for blood sugar wellness

Through this partnership, Caregen aims to further strengthen its presence in the U.S. market and expand access to peptide-based wellness solutions.

We were pleased to welcome representatives from PT Herca Cipta Derma to Caregen for an on-site visit and meeting ✨

During the visit, we introduced Caregen’s innovative peptide technology and shared insights into our R&D capabilities and global business vision.

It was a valuable opportunity to strengthen mutual understanding and discuss future collaboration possibilities together with
Mr. Mirco Setiadji (CEO).

We sincerely appreciate the visit and look forward to building a successful partnership ahead.

🗓️ May 20, 2026

케어젠 김은미 부사장님의
‘2026 올해의 발명왕’ 선정 소식을 기념하며,
오늘 사내 수상식을 진행했습니다🏆

제61회 발명의 날 기념식에서
여성 발명가 최초로 ‘올해의 발명왕’에 선정되어
그 의미를 더욱 빛낸 뜻깊은 순간이었습니다.

케어젠은 앞으로도 독자적인 펩타이드 연구 역량과
혁신적인 바이오 기술을 바탕으로 새로운 가치를 만들어가며
글로벌 바이오 산업의 미래를 선도해 나가겠습니다✨

케어젠의 여정에 앞으로도 많은 관심과 응원 부탁드립니다.

-------------------------------------------------------------------

To celebrate the achievement of
Caregen Vice President Kim Eun-mi being named
the “2026 Inventor of the Year,”
an internal award ceremony was held today at Caregen🏆

At the 61st Inventors’ Day Ceremony,
she became the first-ever female recipient of this honor,
making the moment even more meaningful and remarkable.

Caregen will continue to lead the future of the global biotech industry
through its proprietary peptide research capabilities
and innovative biotechnology, creating new value along the way✨

We appreciate your continued interest and support
for Caregen’s journey ahead.

We were honored to welcome representatives from BCMED to Caregen for an on-site visit and meeting ✨

During the visit, we introduced Caregen’s innovative peptide technology and shared insights into our R&D capabilities and global business vision.

It was a meaningful opportunity to strengthen mutual understanding and discuss future collaboration possibilities together with
CEO, Alvaro de Freitas Almeida and Danielly Dantas Almeida.

We sincerely appreciate the visit and look forward to building a successful partnership ahead.

🗓️ May 18, 2026

globalpartnership